During the RWP ( LDX , n = 78 ; placebo , n = 79 ) , significantly fewer patients receiving LDX met treatment failure criteria ( 15.8 % ) compared with those receiving placebo ( 67.5 % ; difference = -51.7 % ; 95 % confidence interval = -65.0 , -38.5 ; p < .001 ) .